Clinical Trial Update: The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the effectiveness of L-ornithine-L-aspartate (LOLA) for reducing plasma ammonia in cirrhotic patients after TIPS, across P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis
• Esophageal Variceal Bleeding
• Portal Hypertension

Drugs mentioned

• L-ornithine-L-aspartate (L-ornithine-L-aspartate)

Snippet

Sponsor: Air Force Military Medical University, China | Conditions: Decompensated Cirrhosis, Portal Hypertension | Phase 2, Phase 3 | Status: COMPLETED